large-scale office-based study use new class non-sedating antihistamines report CEN agents class antihistamines wide variety family practice patients Phase IV prospective sequence open-label design patients allergic rhinitis AR astemizole terfenadine resultant treatment groups typical family practices comparable demographics signs symptoms allergic rhinitis clinical profile groups astemizole patients history AR frequency family history AR Patients weeks analyses frequency severity signs symptoms AR patient complaints groups Self-reported improvement quality life measures group differences treatments positive-rated outcomes final overall assessment physicians patients rating success therapy physicians ratings excellent patients ratings much astemizole physicians ratings good patients ratings terfenadine 